DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qp3s33/investigation) has announced the addition of the "Investigation Report on China Insulin Detemir Market, 2010-2019" report to their offering. Insulin Detemir, a new long-acting soluble (avoiding the common side effects of non-solvent insulin) human insulin analogue, was made by Novo Nordisk through energetic engineering. It came into the American market in 2005 and brought in sales revenue of USD 2 b
| < Prev | Next > |
|---|
